Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
May 31, 2026 37.59%
February 28, 2026 36.08%
November 30, 2025 37.29%
August 31, 2025 34.40%
May 31, 2025 30.75%
February 28, 2025 39.35%
November 30, 2024 38.80%
August 31, 2024 39.84%
May 31, 2024 47.92%
February 29, 2024 50.53%
November 30, 2023 50.85%
August 31, 2023 50.99%
May 31, 2023 50.94%
February 28, 2023 49.47%
November 30, 2022 48.92%
August 31, 2022 47.05%
May 31, 2022 46.40%
February 28, 2022 44.77%
November 30, 2021 46.43%
August 31, 2021 46.77%
May 31, 2021 45.27%
February 28, 2021 46.14%
November 30, 2020 46.27%
August 31, 2020 46.01%
May 31, 2020 47.43%
Date Value
February 29, 2020 45.39%
November 30, 2019 47.33%
August 31, 2019 47.52%
May 31, 2019 46.04%
February 28, 2019 45.68%
November 30, 2018 46.72%
August 31, 2018 46.90%
May 31, 2018 44.86%
February 28, 2018 47.00%
November 30, 2017 47.91%
August 31, 2017 48.16%
May 31, 2017 47.57%
February 28, 2017 46.25%
November 30, 2016 48.05%
August 31, 2016 48.39%
May 31, 2016 46.46%
February 29, 2016 45.87%
November 30, 2015 48.01%
August 31, 2015 50.48%
May 31, 2015 47.96%
February 28, 2015 49.27%
November 30, 2014 49.97%
August 31, 2014 50.41%
May 31, 2014 47.63%
February 28, 2014 49.53%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
IDEXX Laboratories, Inc. 64.07%
QuidelOrtho Corp. 35.75%
Aspira Women's Health, Inc. 55.28%
VolitionRX Ltd. 28.37%
Lucid Diagnostics, Inc. -13.23%

Gross Profit Margin (Quarterly) Related Metrics